Background. Adiponectin (ADPN) levels are consistently elevated among patients with
advanced chronic kidney disease, but its relationship with cardiovascular outcomes in this …

Background: Adiponectin (ADPN) levels are consistently elevated among patients with
advanced chronic kidney disease, but its relationship with cardiovascular outcomes in this …

Objective Adiponectin (ADPN) has been shown to protect against cardiovascular disease for
the general population with problematic metabolic syndrome. However, it remains unclear …

Adiponectin (ADPN), which is a secretory protein of adipose tissue, attenuates endothelial
inflammatory responses in vitro. Among human subjects, plasma ADPN concentrations are …

Aims: Our aim was to evaluate the prognostic value of 2 measurements of serum
adiponectin levels for all-cause mortality and cardiovascular (CV) mortality in uremic …

Abstract Background/Aim: Plasma adiponectin may play a protective role in the
pathogenesis of cardiovascular disease in hemodialysis (HD) patients. We examined the …

Adiponectin is an adipocyte-specific cytokine that has a protective role in the development of
cardiovascular morbidities. As chronic kidney disease progresses, adiponectin levels …

Background In the general population, circulating adiponectin is associated with a favorable
cardiovascular risk profile (eg, lower triglycerides and body fat) and decreased mortality …

Adiponectin is presumed to possess antiatherogenic and cardioprotective properties.
Limited data exist on the relationship between adiponectin and mortality in the earlier stages …

Background: Adiponectin, a cytokine with anti-inflammatory properties that is secreted from
adipose tissue, is associated with insulin resistance. Adiponectin has been shown to be a …